Genedx Holdings Corp (WGS)

Mar 20, 2025, 4:05 PM EDT - 13 days ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 18, 2025, 7:05 AM EDT - 15 days ago

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Mar 13, 2025, 8:30 AM EDT - 20 days ago

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Mar 13, 2025, 8:30 AM EDT - 20 days ago

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

Mar 12, 2025, 1:13 PM EDT - 21 days ago

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

Mar 4, 2025, 8:30 AM EST - 4 weeks ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Feb 25, 2025, 10:00 AM EST - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Feb 24, 2025, 11:00 AM EST - 5 weeks ago

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Feb 24, 2025, 10:00 AM EST - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Feb 23, 2025, 10:00 AM EST - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 5 weeks ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 20, 2025, 10:00 AM EST - 5 weeks ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 19, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Feb 19, 2025, 9:29 AM EST - 6 weeks ago

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

Feb 18, 2025, 3:54 PM EST - 6 weeks ago

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

Feb 18, 2025, 11:02 AM EST - 6 weeks ago

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

Feb 18, 2025, 6:00 AM EST - 6 weeks ago

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Feb 17, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation

Feb 14, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Reach Out

Feb 13, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect

Feb 13, 2025, 8:30 AM EST - 6 weeks ago

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

Feb 12, 2025, 4:05 PM EST - 7 weeks ago

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 10:00 AM EST - 7 weeks ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation

Feb 10, 2025, 12:00 PM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation

Feb 10, 2025, 8:30 AM EST - 7 weeks ago

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment

Jan 28, 2025, 4:30 PM EST - 2 months ago

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

Jan 16, 2025, 2:03 AM EST - 2 months ago

GeneDx Holdings: A Phenomenal Comeback With More Room To Run

Jan 13, 2025, 8:30 AM EST - 2 months ago

GeneDx Announces Preliminary 2024 Financial Results

Jan 9, 2025, 8:30 AM EST - 2 months ago

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

Jan 8, 2025, 8:30 AM EST - 3 months ago

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Jan 2, 2025, 11:46 PM EST - 3 months ago

Best-Performing Stocks Of 2024

APP BYRN CADL DAVE INOD JANX LUNR

Jan 2, 2025, 4:01 PM EST - 3 months ago

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

Dec 16, 2024, 4:05 PM EST - 3 months ago

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference